NIKKEI 225
32,357.42 +499.80 (+1.57%) HANG SENG
17,809.66 +436.66 (+2.51%) CRUDE OIL
90.96 +0.17 (+0.19%) GOLD FUTURES
1,861.40 -4.70 (-0.25%) DOW
33,507.50 -158.80 (-0.47%) Bitcoin GBP
22,837.99 +686.50 (+3.10%)
Roche Holding AG (RHHBY)
| Previous close | 33.95 |
| Open | 34.47 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 33.93 - 34.47 |
| 52-week range | 33.70 - 43.32 |
| Volume | |
| Avg. volume | 1,558,660 |
| Market cap | 220.83B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 18.24 |
| EPS (TTM) | 1.86 |
| Earnings date | N/A |
| Forward dividend & yield | 1.28 (3.77%) |
| Ex-dividend date | 16 Mar 2023 |
| 1y target est | 42.98 |
ZacksIonis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs
Per the agreement, Ionis (IONS) will grant exclusive global rights to Roche to develop and market two novel RNA-therapeutics for Alzheimer's and Huntington's diseases.
Simply Wall St.Are Roche Holding AG's (VTX:ROG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Roche Holding (VTX:ROG) has had a rough three months with its share price down 8.6%. However, stock prices are usually...
ReutersRoche open to big acquisitions 'if it makes scientific and financial sense' - CEO tells newspaper
Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its shares from Novartis. "Of course, we also look externally for opportunities," Schinecker, who became Roche CEO in March, told Swiss newspaper NZZ Am Sonntag in an article to be published on Sunday. "If it makes scientific and financial sense, we can also imagine a large acquisition," he added.
